2, 2025 Cell Reports Medicine, The expanding benefits of GLP-1 medicines, July 15, 2025 Endocrine Practice, Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes, Nov
they measure the effect of varying an input factor alone, averaged over variations in all other inputs
The athletic performance peptide guide covers how various compounds intersect with training goals
Unlike many weight loss programs that simply prescribe one or two medications and send patients on their way, we evaluate the full pictureconsidering medications, metabolic health, lifestyle factors, and underlying conditions that may be affecting weight loss
This omission makes it impossible to critically assess the robustness of the original findings
There were also further reductions in mortality, stroke, and cardiac arrest at one year